Predictive value of serum CEA, CA19-9 and CA-125 in diagnosis of liver metastases from colorectal cancer in the Chinese population

Hepato-Gastroenterology

Volumn 60, Issue 126, 2013, Pages 1297-1301

  Zhang, Di ^a   Yu, Mingxia ^a   Xu, Tangpeng ^a   Hu, Fen ^a   Li, Xiaogai ^a   Xiong, Bin ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

CA 125; CA19 9; CEA; Liver metastases from colorectal cancer

Indexed keywords

CA 125 ANTIGEN; CA 19-9 ANTIGEN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CHINESE; COLORECTAL CANCER; DISEASE MARKER; FEMALE; HEPATITIS B; HUMAN; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CA-125 ANTIGEN; CA-19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 84885710676     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge121125     Document Type: Article

References (22)

1. Amersi F, Agustin M and Ko CY: Colorectal cancer: epidemiology, risk factors, and health services. Clin Colon Rectal Surg 2005; 18:133-140. (Pubitemid 41262741)
2. Noura S, Ohue M, Shingai T, et al.: Brain metastasis from colorectal cancer: Prognostic factors and survival. J Surg Oncol 2012.
3. Zdenkowski N, Chen S, van der Westhuizen A and Ackland S:Curative Strategies for Liver Metastases from Colorectal Cancer: A Review. Oncologist 2012.
4. Martin R, Paty P, Fong Y, et al.: Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis. J Am Coll Surg 2003; 197:233-241; discussion 241-232.
5. Rees M, Tekkis PP, Welsh FK, et al.: Evaluation of long-term survival after hepatic resection for metastatic colorectal cancer: a multifactorial model of 929 patients. Ann Surg 2008; 247:125-135.
6. Weitz J, Koch M, Debus J, et al.: Colorectal cancer. Lancet 2005; 365:153-165. (Pubitemid 40091806)
7. Christenson RH, Cervelli DR, Sterner J, et al.: Analytical performance and clinical concordance of the cancer biomarkers CA 15-3, CA 19-9, CA 125 II, Carcinoembryonic Antigen, and Alpha-Fetoprotein on the Dimension Vista(R) System. Clin Biochem 2011; 44:1128-1136.
8. Sato H, Usuda N, Kuroda M, et al.: Significance of serum concentrations of E-selectin and CA19-9 in the prognosis of colorectal cancer. Jpn J Clin Oncol 2010; 40:1073-1080.
9. Ohlsson L, Israelsson A, Oberg A, et al.: Lymph node CEA and MUC2 mRNA as useful predictors of outcome in colorectal cancer. Int J Cancer 2011.
10. Gwak JH, Oh BY, Lee RA, et al.:Clinical applications of radio-frequency ablation in liver metastasis of colorectal cancer. J Korean Soc Coloproctol 2011; 27:202-210.
11. Yang XQ, Li Y, Chen C, et al.: Preoperative serum carbohydrate antigen 125 level is an independent negative prognostic marker for overall survival in colorectal cancer. Med Oncol 2011; 28:789-795.
12. Wu XZ, Ma F and Wang XL: Serological diagnostic factors for liver metastasis in patients with colorectal cancer. World J Gastroenterol 2010; 16:4084-4088.
13. Siriwardana RC, Wijesuriya SR, Kumarage SK and Deen KI: Synchronous liver metastasis in colorectal cancer in Sri Lanka. Indian J Gastroenterol 2010; 29:149-151.
14. Mitsuyama Y, Shiba H, Haruki K, et al.: Carcinoembryonic antigen and carbohydrate antigen 19-9 are prognostic predictors of colorectal cancer with unresectable liver metastasis. Oncology letters 2012; 3:767-771.
15. Zhang S, Gao F, Luo J and Yang J: Prognostic factors in survival of colorectal cancer patients with synchronous liver metastasis. Colorectal Dis 2010; 12:754-761.
16. Takahashi S, Konishi M, Nakagohri T, et al.: Short time to recurrence after hepatic resection correlates with poor prognosis in colorectal hepatic metastasis. Jpn J Clin Oncol 2006; 36:368-375. (Pubitemid 44043926)
17. Chuang SC, Su YC, Lu CY, et al.: Risk factors for the development of metachronous liver metastasis in colorectal cancer patients after curative resection. World J Surg 2011; 35:424-429.
18. Fuszek P, Lakatos P, Tabak A, et al.: Relationship between serum calcium and CA 19-9 levels in colorectal cancer. World J Gastroenterol 2004; 10:1890-1892. (Pubitemid 39029286)
19. Hwang GI, Yoo CH, Sohn BH, et al.:Predictive value of preoperative serum CEA, CA19-9 and CA125 levels for peritoneal metastasis in patients with gastric carcinoma. Cancer Res Treat 2004; 36:178-181.
20. McCall JL, Black RB, Rich CA, et al.:The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum 1994; 37:875-881. (Pubitemid 24281920)
21. Lee WS, Kim MJ, Yun SH, et al.:Risk factor stratification after simultaneous liver and colorectal resection for synchronous colorectal metastasis. Langenbecks Arch Surg 2008; 393:13-19. (Pubitemid 350196891)
22. Kim YW, Ko YT, Kim NK, et al.:A comparative study of protein expression in primary colorectal cancer and synchronous hepatic metastases: the significance of matrix metalloproteinase-1 expression as a predictor of liver metastasis. Scand J Gastroenterol 2010; 45:217-225.